The aim of the study was to prepare and evaluate the
potential
use of poly(lactic acid)/poly(vinyl alcohol) (PLA/PVA) nanoparticle
formulations as a drug delivery system. The nanoparticle formulations
were successfully developed by the double emulsification/solvent evaporation
method. The developed formulations were optimized using the quality
by design approach of the ICH Q8 (Pharmaceutical Development) guideline.
In the studies, the effects of emulsifying devices, evaporation technique,
centrifugation effect, and polymer concentrations on the physicochemical
parameters of the formulations were investigated to obtain the best
results. Furthermore, the prepared formulations were evaluated for
clarity, particle size, distribution, zeta potential, surface and
morphological features, preparation efficiency, and long-term stability.
Based on the obtained results, the nanoparticle formulation containing
12.5% PLA, 1% primer, and seconder PVA has a suitable particle size
(181.7 ± 2.194 nm) and distribution (0.104 ± 0.049), zeta
potential (−0.88 ± 0.45 mV), and high preparation efficiency
(65.38%), and nanoparticles were spherical, had a smooth surface,
and were stable up to 12 months. In conclusion, this novel formulation
can be used as a potential drug delivery system.